Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia

NATerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Metabolic Syndrome
Interventions
DRUG

Pravastatin, Fenofibrate, Metformin, Orlistat, irbesartan

The intervention in the 4 patients consisted in dietary recommendations, advice regarding increasing physical activity, and use of Orlistat 60 mg three times daily. No other drugs were prescribed.

OTHER

As selected by community physician

As selected by community physician

Trial Locations (1)

11004

Zucker Hillside Hospital, Glen Oaks

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Northwell Health

OTHER

NCT00794963 - Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia | Biotech Hunter | Biotech Hunter